Efficacy of cyanoacrylate tissue adhesive in the management of corneal thinning and perforation due to microbial keratitis

The Ocular Surface - Tập 18 - Trang 795-800 - 2020
Rohan Bir Singh1, Shuyan Zhu1, Ann Yung1, Thomas H. Dohlman1, Reza Dana1, Jia Yin1
1Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, 02114, USA

Tài liệu tham khảo

Whitcher, 2001, Corneal blindness: a global perspective, Bull World Health Organ, 79, 214 Collier, 2014, Estimated burden of keratitis — United States, 2010, Morb Mortal Wkly Rep, 63, 1027 Webster, 1968, The use of adhesive for the closure of corneal perforations, Arch Ophthalmol, 80, 705, 10.1001/archopht.1968.00980050707004 Yin, 2019, Outcomes of cyanoacrylate tissue adhesive application in corneal thinning and perforation, Cornea, 38, 668, 10.1097/ICO.0000000000001919 Moorthy, 2010, Clinical experience with N-butyl cyanoacrylate tissue adhesive in corneal perforations secondary to herpetic keratitis, Cornea, 29, 971, 10.1097/ICO.0b013e3181cbfa13 Leahey, 1993, Clinical experience with N-butyl cyanoacrylate (Nexacryl) tissue adhesive, Ophthalmology, 100, 173, 10.1016/S0161-6420(93)31674-X Bailey, 1976, New design principles for visual acuity letter charts, Optom Vis Sci, 53, 740, 10.1097/00006324-197611000-00006 Holladay, 2004, Msee. Visual acuity measurements, J Cataract Refract Surg, 30, 287, 10.1016/j.jcrs.2004.01.014 Sharma, 2003, Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations, Ophthalmology, 110, 291, 10.1016/S0161-6420(02)01558-0 Refojo, 1968, Evaluation of adhesives for corneal surgery, Arch Ophthalmol, 80, 645, 10.1001/archopht.1968.00980050647013 Bhende, 2002, In vitro assessment of microbial barrier properties of dermabond ® topical skin adhesive, Surg Infect, 3, 251, 10.1089/109629602761624216 Jandinski, 1971, In vitro effects of isobutyl cyanoacrylate on four types of bacteria, J Dent Res, 50, 1557, 10.1177/00220345710500063301 Eiferman, 1983, Antibacterial effect of cyanoacrylate glue, Arch Ophthalmol, 101, 958, 10.1001/archopht.1983.01040010958022 Pereira de Almeida Manzano, 2006, Antibacterial analysis in vitro of ethyl-cyanoacrylate against ocular pathogens, Cornea, 25, 350, 10.1097/01.ico.0000183490.16131.e3 Romero, 2008, Different application volumes of ethyl-cyanoacrylate tissue adhesive can change its antibacterial effects against ocular pathogens in vitro, Curr Eye Res, 33, 813, 10.1080/02713680802437692 Rushbrook, 2014, The antibacterial effect of 2-octyl cyanoacrylate (Dermabond®) skin adhesive, J Infect Prev, 15, 236, 10.1177/1757177414551562 Quinn, 1997, A randomized trial comparing octylcyanoacrylate tissue adhesive and sutures in the management of lacerations, J Am Med Assoc, 277, 1527, 10.1001/jama.1997.03540430039030 Weiss, 1983, The use of tissue adhesive in corneal perforations, Ophthalmology, 90, 610, 10.1016/S0161-6420(83)34508-5 Moschos, 1997, Clinical experience with cyanoacrylate tissue adhesive, Doc Ophthalmol, 93, 237, 10.1007/BF02569064 Cavanaugh, 1991, Infectious keratitis and cyanoacrylate adhesive, Am J Ophthalmol, 111, 466, 10.1016/S0002-9394(14)72382-7 Garg, 2003, Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis, Cornea, 22, 405, 10.1097/00003226-200307000-00003 Dogan, 2019, In vitro antifungal effect of acrylic corneal glue (N-Butyl-2-Cyanoacrylate), Cornea, 38, 1563, 10.1097/ICO.0000000000002061 Khalifa, 2010, Management of nontraumatic corneal perforation with tectonic drape patch and cyanoacrylate glue, Cornea, 29, 1173, 10.1097/ICO.0b013e3181d5d996 Gandhewar, 2013, Double drape tectonic patch with cyanoacrylate glue in the management of corneal perforation with iris incarceration, Cornea, 32, e137, 10.1097/ICO.0b013e3182801809 Vasseneix, 2006, Surgical management of nontraumatic corneal perforations: an 8-year retrospective study, J Fr Ophtalmol, 29, 751, 10.1016/S0181-5512(06)73844-X Chen, 2007, Comparison of the bacteriostatic effects, corneal cytotoxicity, and the ability to seal corneal incisions among three different tissue adhesives, Cornea, 26, 1228, 10.1097/ICO.0b013e3181506129